240 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

—

Fill in a starting date and a closing date for the period your query is about: DD-MM-YYYY

You can select a specific type of a publication you are looking for, such as press releases or speeches

Tisagenlecleucel-T (Kymriah®) for the treatment of ALL

Zorginstituut Nederland carried out an assessment of the medicinal product tisagenlecleucel-T (Kymriah®) for the treatment of ...

Report | 18-12-2018

Lesinurad (Zurampic®) for the treatment of hyperuricaemia in gout patients

Zorginstituut Nederland carried out an assessment whether lesinurad (Zurampic®) is interchangeable with any product that is ...

Report | 04-12-2018

Letermovir (Prevymis®) in cases of adult CMV-seropositive recipients of an allogenic haemotopoietic stem cell transplant (HSCT)

Zorginstituut Nederland has carried out an assessment whether letermovir (Prevymis®) is interchangeable with a medicinal product ...

Report | 27-11-2018

Final report FAIR Data feasibility assessment

This is the final report of the FAIR Data part of the FAIR Data and Personal Health Train feasibility assessment. In this ...

Report | 31-10-2018

Final report on the Personal Health Train feasibility assessment

This is the final report of the FAIR Data part of the feasibility assessment on FAIR Data & the Personal Health Train (PHT). In ...

Report | 31-10-2018

Package advice in practice - Deliberations for arriving at a fair package

The public debate pays a lot of attention to how we can continue to pay for health care in the future. A question that the ...

Report | 11-09-2018

Semaglutide (Ozempic®) for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise

Zorginstituut Nederland carried out a marginal assessment of whether semaglutide (Ozempic®) is interchangeable with a drug ...

Report | 28-08-2018

Working method for the Zinnige Zorg (appropriate care) Programme

Zorginstituut Nederland’s motto is "Taking care of good health care: no more and no less than necessary". Every citizen must be ...

Brochure | 27-08-2018

Hydrocortisone sodium phosphate (Softacor®) for the treatment of mild non-infectious allergic or inflammatory conjunctival diseases

Zorginstituut Nederland has carried out an assessment of the medicinal product hydrocortisone sodium phosphate (Softacor®) can be ...

Report | 06-08-2018

Room for improvement analysis: Peripheral Arterial Disease – Zinnige Zorg

This Room for Improvement Analysis describes the research and the resulting actions and agreements that focus on further ...

Report | 01-08-2018

Go to